NCT01706380

Brief Summary

The present study, in an out-patient setting for substance use treatment in adolescents, examines the effect on treatment retention of a mobile telephone follow-up technique (interactive voice response), with or without personal feedback. Subjects in treatment for substance use disorders will be followed by automated mobile telephone contact with questions about psychiatric symptoms and substance use, and the investigators hypothesize that this technique, including a personal feedback reporting back to the client whether his or her status is changing in one way or another, may increase the treatment retention, possibly by means of an intensified treatment contact.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

October 8, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 15, 2012

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

March 16, 2021

Status Verified

March 1, 2021

Enrollment Period

1.2 years

First QC Date

October 8, 2012

Last Update Submit

March 12, 2021

Conditions

Substance Use Disorders

Keywords

Substance use disordersAdolescentsRetentionMobile telephoneFollow-upInteractive voice response

Outcome Measures

Primary Outcomes (1)

  • Retention in substance use disorder treatment

    Duration of retention in treatment and whether the client remains in treatment at 3 months or not.

    3 months

Secondary Outcomes (2)

  • Improvement in substance use

    3 months

  • Improvements in psychiatric symptoms

    3 months

Other Outcomes (3)

  • Clinical course with respect to emergency visits

    12 months

  • Clinical course with respect to hospitalizations

    12 months

  • Clinical course with respect to repeated treatment episodes

    12 months

Study Arms (2)

Interactive voice response with personal feedback

EXPERIMENTAL

Interactive voice response follows the client twice weekly for 3 months with respect to symptoms and substance use, in both arms. This intervention group also receives a personalized and automated feedback describing whether the symptom status of the patient is better, worse or equal, compared to the preceding follow-up.

Behavioral: Interactive voice response with personal feedback

Interactive voice response without personal feedback

ACTIVE COMPARATOR

This control group is also followed with identical interactive voice response follow-up, addressing symptoms and substance use, but without the personal feedback.

Behavioral: Interactive voice response without personal feedback

Interventions

Interactive voice response with personal feedbackBEHAVIORAL

Personal feedback is given at the end of each automated telephone follow-up call, and reports back to the patient whether his och her symptom status is better, worse or equal, compared to the previous telephone call.

Interactive voice response with personal feedback
Interactive voice response without personal feedbackBEHAVIORAL

Control condition. Identical follow-up but without personal feedback.

Interactive voice response without personal feedback

Eligibility Criteria

AgeUp to 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patient applying for substance use disorder treatment at out-patient facility Maria Malmö, Malmö, Sweden, who are less than 25 years old and who provide written informed consent to participate in the study.

You may not qualify if:

  • Patients who do not provide written informed consent to the study, or whose psychiatric condition or language difficulties make it impossible for them to understand patient information and give informed consent to the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maria Malmö, Dept of Psychiatry Skane and City of Malmö, Sweden

Malmo, Skåne County, 205 02, Sweden

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

October 8, 2012

First Posted

October 15, 2012

Study Start

October 1, 2012

Primary Completion

December 1, 2013

Study Completion

April 1, 2014

Last Updated

March 16, 2021

Record last verified: 2021-03

Locations

SE(1)